Functional Luminal Imaging Probe (FLIP) Topography Use in Patients With Scleroderma and Trouble Swallowing

Withdrawn before enrolling · Not applicable

Conditions studied: Scleroderma, Dysphagia, GERD - Gastro-Esophageal Reflux Disease

In brief

FLIP topography has been FDA cleared to evaluate a variety of esophageal conditions, but has never been evaluated in patients with scleroderma. The investigators hope to evaluate this technology in patients who have scleroderma and various esophageal symptoms, and compare to non-scleroderma patients.

Key facts

Study ID

NCT03270722

Run by

Stanford University

People needed

0

Starts

2018-01-01

Expected to finish

2020-05-01

Last updated by the study team

2021-01-20

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Must have a clinical indication for upper endoscopy (recruiting patients both with scleroderma and without)

You may not qualify if…

• not healthy enough to undergo an upper endoscopy
• mass, stricture, ring, or web present on upper endoscopy
• history of esophageal cancer
• history of esophageal surgery

Where it is running

• Stanford Healthcare — Redwood City, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.